country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Cat. No.: HY-P991581

Copy Link Print Information

Biologically Validated

MK-2060

Name: MK-2060
Brand: MedChemExpress
SKU: HY-P991581
Price: 320.00 USD
Availability: InStock
Rating: 5 (1 reviews)

고객리뷰

Based on 1 Customer Validation

MK-2060 is a monoclonal antibody factor XI inhibitor. MK-2060 binds to the A3 domain of coagulation factor XI (FXI), prevents FXIIa-mediated FXI activation, and blocks the binding/activation of FIX with FXIa, locking the zymogen in an inactive/non-activatable conformation, thereby prolonging aPTT. MK-2060 can be used in research on end-stage renal disease, ESRD requiring hemodialysis, and arteriovenous graft thrombosis.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

Purity : ≥99.0%
CAS No.: 2812480-88-7
분자량:145.33 kDa

보관:

Shipping with dry ice

Please store the product under the recommended conditions in the Certificate of Analysis.

MK-2060 Chemical Structure

CAS No.: 2812480-88-7

사이즈

가격

재고

수량

Amount: USD 0.00

* 장바구니에 담기 전 물품의 수량을 선택해 주십시오.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biological Activity
- 제품 설명
- Isotype
- Recommend Isotype Controls
- Species Reactivity
- IC₅₀ & Target
- In Vitro
- Gene ID
- Accession
- Conjugated
- Reconsititution
- 신청
- Verified Bioactivity
Chemical Information
순도&문서
References
Calculators
Help & FAQs
Classifications
Bioz

Biological Activity

제품 설명

Isotype

Human IgG4 kappa

Recommend Isotype Controls

Human IgG4 (S228P) kappa, Isotype Control

Species Reactivity

Human

IC₅₀ & Target

F11/Factor XI

In Vitro

MK-2060 binds to the A3 domain of FXI, prevents FXIIa from activating FXI, and blocks the binding of FIX to FXIa; it belongs to the class of antibodies that lock the zymogen FXI in an inactive conformation, producing a state resembling FXI deficiency^[5].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Gene ID

2160 [NCBI]

Accession

P03951

Conjugated

Unconjugated

Reconsititution

The product can be reconstituted/diluted with sterile PBS or saline.

신청

ELISA, FACS, Functional assay

Verified Bioactivity

Immobilized Human Factor XI Protein, His Tag can bind MK-2060. The EC₅₀ for this effect is 59.5 ng/mL.

Chemical Information

CAS No. 2812480-88-7
Appearance Liquid
분자량 145.33 kDa
Color Colorless to light yellow
SMILES

N/A
선적

Shipping with dry ice.
Formulation

Please refer to the lot-specific COA for specific buffer information.
보관

Please store the product under the recommended conditions in the Certificate of Analysis.

순도&문서

Select Batch:

Purity: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (272 KB)
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Inhibitory Antibodies User Guide (603 KB)

References

[1]. Presume J, et al. Factor XI Inhibitors: A New Horizon in Anticoagulation Therapy. Cardiology and therapy. 2024 Mar;13(1):1-16.

[2]. Jin M, et al. Potential Role of Contact Pathway Factors in Catheter-Related Thrombosis: Emerging Evidence and Therapeutic Strategies. Biomolecules. 2026 Aug 29;16(9):1256.

[3]. Holzhauer S, et al. Factor XI Inhibition: Adult Evidence and Paediatric Considerations. Hamostaseologie. 2026 Aug 07.

[4]. De Caterina R, et al. Factor XI inhibitors: cardiovascular perspectives. European heart journal. 2023 Jan 21;44(4):280-292. [Content Brief]

[5]. Gailani D, et al. Measuring up: the need for new assays for factor (F) XI/FXIa inhibitor therapies[J]. Research and Practice in Thrombosis and Haemostasis, 2026.

[6]. Del Toro-Mijares R, et al. Venous thromboembolism prevention and treatment with factor XI/XIa inhibitors: current status and future perspectives. Journal of thrombosis and thrombolysis. 2026 Jan;59(1):23-34.

Calculators

몰농도 계산기

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

농도 희석 계산기

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

견적 받기 해외재고보유

Other size

견적 받기